A study by Norwegian researchers showed that generics substitution may lead to lack of compliance in Pakistani immigrants in Norway, due to misconceptions and confusion with counterfeit drugs [1].
- INICIO
-
Genéricos
Novedades
- Five Chinese companies join UN’s MPP for Covid-19 medicines
- South Korean companies to make generic Bridion and COVID-19 drugs
- Revlimid (lenalidomide) generics launch across Europe
- Cancer and diabetes generic treatments receive positive opinion from EMA’s CHMP
Investigación
- The cost of developing drugs and use of generics
- Re-evaluation of the use of generics, especially when treating conditions such as epilepsy
- La reutilización de medicamentos genéricos puede ahorrar tiempo y dinero
- Availability of medicines and the sustainable development of the national health system in Russia
-
Biosimilares
Novedades
- Lucentis biosimilars approved in the UK and Korea
- Nuevos biosimilares de adalimumab se preparan para su lanzamiento en Canadá, EE.UU. y Europa
- FDA approves Amneal’s bevacizumab biosimilar
- Europe: positive opinion for Inpremzia and Truvelog Mix 30 and Stimufend authorized
Investigación
- Patient perspectives on biosimilars in a high uptake country
- Biosimilar adoption and prescribing in Japan: a physician opinion survey
- Innovent and Eli Lilly announce final results for sintilimab plus biosimilar bevacizumab injection
- Totality of evidence supporting approval of Avsola in the treatment of IBD
- MORE EDITORIAL SECTIONS
- Search
Post your comment